Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
HUMULIN R | ELI LILLY CANADA INC | Resolved | 100UNIT | Updated Report | 2024-09-18 | 236640 |
LANCORA | SERVIER CANADA INC | Resolved | 5MG | Updated Report | 2024-09-18 | 237006 |
MYLAN-NAPROXEN/ESOMEPRAZOLE MR | MYLAN PHARMACEUTICALS ULC | Actual shortage | 20MG 500MG | Updated Report | 2024-09-18 | 237812 |
EMEND IV | MERCK CANADA INC | Actual shortage | 150MG | Updated Report | 2024-09-18 | 237846 |
ACCUTANE ROCHE | HOFFMANN-LA ROCHE LIMITED | Resolved | 10MG | Updated Report | 2024-09-18 | 229980 |
TEGRETOL CR | NOVARTIS PHARMACEUTICALS CANADA INC | Anticipated shortage | 200MG | Updated Report | 2024-09-17 | 235978 |
VOLTAREN RAPIDE | NOVARTIS PHARMACEUTICALS CANADA INC | Anticipated shortage | 50MG | Updated Report | 2024-09-17 | 233544 |
TEGRETOL | NOVARTIS PHARMACEUTICALS CANADA INC | Anticipated shortage | 200MG | Updated Report | 2024-09-17 | 235974 |
ACCUTANE ROCHE | HOFFMANN-LA ROCHE LIMITED | Anticipated shortage | 40MG | Updated Report | 2024-09-17 | 229983 |
CELLCEPT | HOFFMANN-LA ROCHE LIMITED | Anticipated shortage | 250MG | New Report | 2024-09-17 | 237837 |
XYLAC | PENDOPHARM DIVISION OF PHARMASCIENCE INC | Actual shortage | 2.5MG | Updated Report | 2024-09-17 | 232696 |
SANTYL | SMITH & NEPHEW INC | Actual shortage | 250UNIT | Updated Report | 2024-09-17 | 193768 |
CADUET | BGP PHARMA ULC | Actual shortage | 80MG 5MG | Updated Report | 2024-09-17 | 234685 |
CLARUS | MYLAN PHARMACEUTICALS ULC | Actual shortage | 10MG | Updated Report | 2024-09-17 | 232550 |
CLARUS | MYLAN PHARMACEUTICALS ULC | Actual shortage | 40MG | Updated Report | 2024-09-17 | 232553 |
MYLAN-INDAPAMIDE | MYLAN PHARMACEUTICALS ULC | Actual shortage | 1.25MG | Updated Report | 2024-09-17 | 232575 |
MYLAN-MIRTAZAPINE | MYLAN PHARMACEUTICALS ULC | Actual shortage | 15MG | Updated Report | 2024-09-17 | 232547 |
MYLAN-MIRTAZAPINE | MYLAN PHARMACEUTICALS ULC | Actual shortage | 45MG | Updated Report | 2024-09-17 | 230092 |
TOBI PODHALER | BGP PHARMA ULC | Anticipated shortage | 28MG | Updated Report | 2024-09-17 | 236492 |
MYLAN-ESCITALOPRAM | MYLAN PHARMACEUTICALS ULC | Anticipated shortage | 10MG | Updated Report | 2024-09-17 | 236497 |
OMNIPAQUE 240 | GE HEALTHCARE CANADA INC | Actual shortage | 518MG | New Report | 2024-09-17 | 237809 |
SANDOZ LOSARTAN HCT | SANDOZ CANADA INCORPORATED | Resolved | 12.5MG 50MG | Updated Report | 2024-09-17 | 236563 |
SANDOZ TELMISARTAN | SANDOZ CANADA INCORPORATED | Resolved | 80MG | Updated Report | 2024-09-17 | 237137 |
SANDOZ AZITHROMYCIN | SANDOZ CANADA INCORPORATED | Actual shortage | 250MG | Updated Report | 2024-09-17 | 237740 |
SANDOZ CANDESARTAN | SANDOZ CANADA INCORPORATED | Actual shortage | 16MG | Updated Report | 2024-09-17 | 237744 |
SANDOZ IRBESARTAN HCT | SANDOZ CANADA INCORPORATED | Actual shortage | 12.5MG 300MG | Updated Report | 2024-09-17 | 237750 |
SANDOZ LISDEXAMFETAMINE CAPSULES | SANDOZ CANADA INCORPORATED | Actual shortage | 50MG | Updated Report | 2024-09-17 | 237754 |
SANDOZ TOLTERODINE LA | SANDOZ CANADA INCORPORATED | Actual shortage | 4MG | Updated Report | 2024-09-17 | 237757 |
SANDOZ FESOTERODINE FUMARATE | SANDOZ CANADA INCORPORATED | Actual shortage | 8MG | Updated Report | 2024-09-17 | 237761 |
SANDOZ RIVASTIGMINE | SANDOZ CANADA INCORPORATED | Actual shortage | 3MG | Updated Report | 2024-09-17 | 237764 |
SANDOZ RIVASTIGMINE | SANDOZ CANADA INCORPORATED | Actual shortage | 4.5MG | Updated Report | 2024-09-17 | 237768 |
RISPERIDONE | SANIS HEALTH INC | Resolved | 0.25MG | Updated Report | 2024-09-17 | 233527 |
LOXAPAC IM | SANDOZ CANADA INCORPORATED | Resolved | 50MG | Updated Report | 2024-09-17 | 236567 |
OMNIPAQUE 240 | GE HEALTHCARE CANADA INC | Actual shortage | 518MG | Updated Report | 2024-09-17 | 237683 |
SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE | SANDOZ CANADA INCORPORATED | Actual shortage | 2.5% 0.3% | Updated Report | 2024-09-17 | 237724 |
SANDOZ ALFUZOSIN | SANDOZ CANADA INCORPORATED | Actual shortage | 10MG | Updated Report | 2024-09-17 | 237728 |
SANDOZ AMOXI-CLAV TABLET | SANDOZ CANADA INCORPORATED | Actual shortage | 125MG 500MG | Updated Report | 2024-09-17 | 237732 |
SANDOZ ATORVASTATIN | SANDOZ CANADA INCORPORATED | Actual shortage | 20MG | Updated Report | 2024-09-17 | 237736 |
LOSARTAN | SANIS HEALTH INC | Resolved | 50MG | Updated Report | 2024-09-17 | 145534 |
LOSARTAN | SANIS HEALTH INC | Resolved | 100MG | Updated Report | 2024-09-17 | 145888 |
BENDAMUSTINE HYDROCHLORIDE FOR INJECTION | ACCORD HEALTHCARE INC | Actual shortage | 25MG | Updated Report | 2024-09-17 | 225238 |
LOSARTAN/HCTZ | SANIS HEALTH INC | Resolved | 12.5MG 50MG | Updated Report | 2024-09-17 | 232005 |
GRAVOL IM | CHURCH & DWIGHT CANADA CORP | Actual shortage | 50MG | Updated Report | 2024-09-17 | 235248 |
ONE-ALPHA | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 2MCG | Updated Report | 2024-09-16 | 213256 |
INHIBACE PLUS | CHEPLAPHARM ARZNEIMITTEL GMBH | Actual shortage | 12.5MG 5MG | Updated Report | 2024-09-16 | 230712 |
MICAFUNGIN SODIUM FOR INJECTION | HIKMA CANADA LIMITED | Actual shortage | 100MG | New Report | 2024-09-16 | 237779 |
LACTATED RINGER'S INJECTION | ICU MEDICAL CANADA INC | Actual shortage | 3.1MG 0.2MG 0.3MG 6MG | Updated Report | 2024-09-16 | 228396 |
SODIUM CHLORIDE INJECTION USP | ICU MEDICAL CANADA INC | Actual shortage | 9MG | Updated Report | 2024-09-16 | 235358 |
CLINDAMYCIN IV INFUSION | SANDOZ CANADA INCORPORATED | Anticipated shortage | 18MG | Updated Report | 2024-09-16 | 236743 |
TIMOLOL MALEATE-EX | SANDOZ CANADA INCORPORATED | Actual shortage | 0.25% | Updated Report | 2024-09-16 | 227853 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
HUMULIN R | ELI LILLY CANADA INC | To be discontinued | 100UNIT | Updated Report | 2024-09-16 | 224344 |
TARO-DIPYRIDAMOLE/ ASA | TARO PHARMACEUTICALS INC | Discontinued | 25MG 200MG | New Report | 2024-09-09 | 237043 |
HUMALOG | ELI LILLY CANADA INC | To be discontinued | 100UNIT | Updated Report | 2024-09-05 | 224347 |
GLUCONORM 2.0MG | NOVO NORDISK CANADA INC | Discontinued | 2.0MG | Updated Report | 2024-09-05 | 201489 |
LEVOPHED | PFIZER CANADA ULC | Discontinued | 1MG | Updated Report | 2024-08-29 | 236113 |
FLAREX | NOVARTIS PHARMACEUTICALS CANADA INC | To be discontinued | 0.1% | New Report | 2024-08-27 | 235987 |
PMS-SOTALOL - 160 MG | PHARMASCIENCE INC | Reversed | 160MG | Updated Report | 2024-08-23 | 234583 |
PIPERACILLIN AND TAZOBACTAM FOR INJECTION | FRESENIUS KABI CANADA LTD | Discontinued | 4.5G 36G | Updated Report | 2024-08-20 | 235203 |
OESCLIM | SEARCHLIGHT PHARMA INC | Discontinued | 50MCG | Updated Report | 2024-08-19 | 234662 |
OESCLIM | SEARCHLIGHT PHARMA INC | Discontinued | 25MCG | Updated Report | 2024-08-19 | 234118 |